COVID-19 Vaccine Trial Stopped Due to Unexplained Illness in Study Participant

Johnson & Johnson announced late Monday it is temporarily pausing recruitment and dosing of its coronavirus vaccine in clinical trials due to an “unexplained illness in a study participant.”

The independent drug safety monitoring board for J&J’s phase 3 ENSEMBLE trial is reviewing the unexpected event. The company did not disclose more information about the affected individual.

“We must respect this participant’s privacy,” J&J said in a statement. “We’re also learning more about this participant’s illness, and it’s important to have all the facts before we share additional information.” (Read more from “COVID-19 Vaccine Trial Stopped Due to Unexplained Illness in Study Participant” HERE)

Follow Joe Miller on Twitter HERE and Facebook HERE